Search icon

MACROCHEM CORPORATION

Company claim

Is this your business?

Get access!

Company Details

Name: MACROCHEM CORPORATION
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Inactive
Date of registration: 17 Apr 2008 (17 years ago)
Date of dissolution: 26 Oct 2011
Entity Number: 3659516
ZIP code: 10011
County: New York
Place of Formation: Delaware
Address: 111 EIGHTH AVENUE, NEW YORK, NY, United States, 10011

DOS Process Agent

Name Role Address
C/O CT CORPORATION SYSTEM DOS Process Agent 111 EIGHTH AVENUE, NEW YORK, NY, United States, 10011

Agent

Name Role Address
CT CORPORATION SYSTEM Agent 111 EIGHTH AVENUE, NEW YORK, NY, 10011

Filings

Filing Number Date Filed Type Effective Date
DP-2089507 2011-10-26 ANNULMENT OF AUTHORITY 2011-10-26
080417000022 2008-04-17 APPLICATION OF AUTHORITY 2008-04-17

Trademarks Section

Serial Number:
77449736
Mark:
SALEXIUM
Status:
ABANDONED - AFTER INTER-PARTES DECISION
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2008-04-16
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SALEXIUM

Goods And Services

For:
Pharmaceutical preparations and formulations used in treatment of cancer, cardiovascular, autoimmune, neurological and infectious diseases
International Classes:
005 - Primary Class
Class Status:
Abandoned
For:
Research and development of technologies for the treatment of cancer, cardiovascular, autoimmune, neurological and infectious diseases
International Classes:
042 - Primary Class
Class Status:
Abandoned
Serial Number:
77449665
Mark:
SALEXIUM PHARMACEUTICALS
Status:
ABANDONED - AFTER INTER-PARTES DECISION
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2008-04-16
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SALEXIUM PHARMACEUTICALS

Goods And Services

For:
Pharmaceutical preparations and formulations used in treatment of cancer, cardiovascular, autoimmune, neurological and infectious diseases
International Classes:
005 - Primary Class
Class Status:
Abandoned
For:
Research and development of technologies for the treatment of cancer, cardiovascular, autoimmune, neurological and infectious diseases
International Classes:
042 - Primary Class
Class Status:
Abandoned

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 28 Mar 2025

Sources: New York Secretary of State